Analgesic efficacy, immunomodulation and complications of Erector spinae plane block in breast cancer surgeries: A randomized controlled trial

Background To investigate the effect and drawbacks of different LA volumes and concentrations of ESPB on postoperative need for opioids and rescue analgesics, post-mastectomy acute neuropathic pain, and NK cells cytotoxicity.Methods 60 breast cancer patients, ranging in age from 18 to 70 and with an...

Full description

Bibliographic Details
Main Authors: Ahmed Mohamed Mohamed Rabah Abdella, Emad Eldin Abd El Monem Areda, Nagwa Ahmed Megahed, Hossam El-Deen Mohammad Ghoneim, Wessam Zakaria El-Amrawy
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Egyptian Journal of Anaesthesia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/11101849.2022.2094070
_version_ 1811332678412140544
author Ahmed Mohamed Mohamed Rabah Abdella
Emad Eldin Abd El Monem Areda
Nagwa Ahmed Megahed
Hossam El-Deen Mohammad Ghoneim
Wessam Zakaria El-Amrawy
author_facet Ahmed Mohamed Mohamed Rabah Abdella
Emad Eldin Abd El Monem Areda
Nagwa Ahmed Megahed
Hossam El-Deen Mohammad Ghoneim
Wessam Zakaria El-Amrawy
author_sort Ahmed Mohamed Mohamed Rabah Abdella
collection DOAJ
description Background To investigate the effect and drawbacks of different LA volumes and concentrations of ESPB on postoperative need for opioids and rescue analgesics, post-mastectomy acute neuropathic pain, and NK cells cytotoxicity.Methods 60 breast cancer patients, ranging in age from 18 to 70 and with an ASA I–II, were randomly assigned to receive ESPB with 20 ml 0.25% bupivacaine (Standard volume ESPB), 40 ml 0.125% bupivacaine (High volume ESPB), or no ESPB (GA only group) after being scheduled for surgery. The primary outcome was total morphine administered over the first 24 postoperative hours. The secondary endpoints were amount of rescue analgesia needed, acute neuropathic pain assessed by DN4 questionnaire, NKC cytotoxicity and complications.Results Total amount of morphine consumed was less in both ESPB groups compared with the control (1.13 ± 1.77 vs. 1.35 ± 3.15 vs. 9.58 ± 5.76, p < 0.001).Ketorolac was less needed, as postoperative rescue analgesic, in both ESPB groups compared with the GA group      Similar incidence of acute postoperative neuropathic pain was observed . NKC cytotoxicity did not differ among the three studied groups; however, the high volume of LA enhanced the postoperative cytotoxicity relative to the preoperative one. No complications of the block had been recorded and the incidence of PONV is less in ESPB groups than the control .Conclusions ESPB is an effective and safe analgesic modality as it attenuates the postoperative need for opioids and rescue analgesics, when bupivacaine is used in a dose of 50 mg with variable volumes and concentrations. It does not alter the incidence of acute post-mastectomy neuropathic pain; nevertheless, it delays its onset and mitigates its severity. Its role in enhancing the NK cells cytotoxicity needs further evaluation.Trial registration NCT04796363Date of registration March 12, 2021
first_indexed 2024-04-13T16:40:34Z
format Article
id doaj.art-064d12f87d1741749c18da53138f3b4c
institution Directory Open Access Journal
issn 1110-1849
language English
last_indexed 2024-04-13T16:40:34Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Egyptian Journal of Anaesthesia
spelling doaj.art-064d12f87d1741749c18da53138f3b4c2022-12-22T02:39:14ZengTaylor & Francis GroupEgyptian Journal of Anaesthesia1110-18492022-12-0138139040010.1080/11101849.2022.2094070Analgesic efficacy, immunomodulation and complications of Erector spinae plane block in breast cancer surgeries: A randomized controlled trialAhmed Mohamed Mohamed Rabah Abdella0Emad Eldin Abd El Monem Areda1Nagwa Ahmed Megahed2Hossam El-Deen Mohammad Ghoneim3Wessam Zakaria El-Amrawy4Department of Anaesthesia and Pain Management, Medical Research Institute, University of Alexandria, Alexandria, EgyptDepartment of Anaesthesia and Surgical Intensive Care, Faculty of Medicine, University of Alexandria, Alexandria, EgyptDepartment of Anaesthesia and Pain Management, Medical Research Institute, University of Alexandria, Alexandria, EgyptDepartment of Immunology and Allergy, Medical Research Institute, University of Alexandria, Alexandria, EgyptDepartment of Anaesthesia and Pain Management, Medical Research Institute, University of Alexandria, Alexandria, EgyptBackground To investigate the effect and drawbacks of different LA volumes and concentrations of ESPB on postoperative need for opioids and rescue analgesics, post-mastectomy acute neuropathic pain, and NK cells cytotoxicity.Methods 60 breast cancer patients, ranging in age from 18 to 70 and with an ASA I–II, were randomly assigned to receive ESPB with 20 ml 0.25% bupivacaine (Standard volume ESPB), 40 ml 0.125% bupivacaine (High volume ESPB), or no ESPB (GA only group) after being scheduled for surgery. The primary outcome was total morphine administered over the first 24 postoperative hours. The secondary endpoints were amount of rescue analgesia needed, acute neuropathic pain assessed by DN4 questionnaire, NKC cytotoxicity and complications.Results Total amount of morphine consumed was less in both ESPB groups compared with the control (1.13 ± 1.77 vs. 1.35 ± 3.15 vs. 9.58 ± 5.76, p < 0.001).Ketorolac was less needed, as postoperative rescue analgesic, in both ESPB groups compared with the GA group      Similar incidence of acute postoperative neuropathic pain was observed . NKC cytotoxicity did not differ among the three studied groups; however, the high volume of LA enhanced the postoperative cytotoxicity relative to the preoperative one. No complications of the block had been recorded and the incidence of PONV is less in ESPB groups than the control .Conclusions ESPB is an effective and safe analgesic modality as it attenuates the postoperative need for opioids and rescue analgesics, when bupivacaine is used in a dose of 50 mg with variable volumes and concentrations. It does not alter the incidence of acute post-mastectomy neuropathic pain; nevertheless, it delays its onset and mitigates its severity. Its role in enhancing the NK cells cytotoxicity needs further evaluation.Trial registration NCT04796363Date of registration March 12, 2021https://www.tandfonline.com/doi/10.1080/11101849.2022.2094070Erector spinae plane blockUltrasound guidedanalgesiaNK cellsimmunomodulation and Breast cancer surgery
spellingShingle Ahmed Mohamed Mohamed Rabah Abdella
Emad Eldin Abd El Monem Areda
Nagwa Ahmed Megahed
Hossam El-Deen Mohammad Ghoneim
Wessam Zakaria El-Amrawy
Analgesic efficacy, immunomodulation and complications of Erector spinae plane block in breast cancer surgeries: A randomized controlled trial
Egyptian Journal of Anaesthesia
Erector spinae plane block
Ultrasound guided
analgesia
NK cells
immunomodulation and Breast cancer surgery
title Analgesic efficacy, immunomodulation and complications of Erector spinae plane block in breast cancer surgeries: A randomized controlled trial
title_full Analgesic efficacy, immunomodulation and complications of Erector spinae plane block in breast cancer surgeries: A randomized controlled trial
title_fullStr Analgesic efficacy, immunomodulation and complications of Erector spinae plane block in breast cancer surgeries: A randomized controlled trial
title_full_unstemmed Analgesic efficacy, immunomodulation and complications of Erector spinae plane block in breast cancer surgeries: A randomized controlled trial
title_short Analgesic efficacy, immunomodulation and complications of Erector spinae plane block in breast cancer surgeries: A randomized controlled trial
title_sort analgesic efficacy immunomodulation and complications of erector spinae plane block in breast cancer surgeries a randomized controlled trial
topic Erector spinae plane block
Ultrasound guided
analgesia
NK cells
immunomodulation and Breast cancer surgery
url https://www.tandfonline.com/doi/10.1080/11101849.2022.2094070
work_keys_str_mv AT ahmedmohamedmohamedrabahabdella analgesicefficacyimmunomodulationandcomplicationsoferectorspinaeplaneblockinbreastcancersurgeriesarandomizedcontrolledtrial
AT emadeldinabdelmonemareda analgesicefficacyimmunomodulationandcomplicationsoferectorspinaeplaneblockinbreastcancersurgeriesarandomizedcontrolledtrial
AT nagwaahmedmegahed analgesicefficacyimmunomodulationandcomplicationsoferectorspinaeplaneblockinbreastcancersurgeriesarandomizedcontrolledtrial
AT hossameldeenmohammadghoneim analgesicefficacyimmunomodulationandcomplicationsoferectorspinaeplaneblockinbreastcancersurgeriesarandomizedcontrolledtrial
AT wessamzakariaelamrawy analgesicefficacyimmunomodulationandcomplicationsoferectorspinaeplaneblockinbreastcancersurgeriesarandomizedcontrolledtrial